Astrana Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $22.5M | $43.1M | $60.7M | $45.2M | $68.9M | $37.7M | $14.1M | $10.8M |
| Depreciation & Amortization | $45.7M | $27.9M | $17.7M | $17.5M | $17.5M | $18.4M | $18.3M | $19.3M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $40.7M | $25.6M | $12.7M | $13.7M | $15.4M | $16.0M | $16.3M | $17.1M |
| Stock-Based Compensation | $38.6M | $34.5M | $22.0M | $16.1M | $6.7M | $3.4M | $1.5M | $1.4M |
| Net Cash from Operating Activities | $114.6M | $52.2M | $68.2M | $82.1M | $70.3M | $46.2M | $13.7M | $25.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $10.1M | $8.0M | $28.5M | $22.9M | $19.2M | $1.2M | $1.0M | $1.2M |
| Business Acquisitions | $548.6M | $146.3M | $6.5M | $16.4M | $2.6M | $11.4M | $49.4M | $0 |
| Net Cash from Investing Activities | $-539.0M | $-192.4M | $-65.5M | $-7.1M | $16.5M | $95.5M | $-180.6M | $-25.2M |
| Financing Activities | ||||||||
| Dividends Paid | $7.9M | $4.0M | $62.1M | $14.0M | $31.1M | $51.3M | $61.7M | $17.8M |
| Stock Repurchases | $25.6M | $900.0K | $10.2M | $9.3M | $5.7M | $537.0K | $7.6M | $5.0M |
| Net Cash from Financing Activities | $569.3M | $135.1M | $3.4M | $-20.1M | $-47.7M | $-51.7M | $163.3M | $-11.2M |
| Net Change in Cash | $144.9M | $-5.1M | $6.1M | $54.9M | $39.1M | $90.0M | $-3.6M | $-10.9M |
| Free Cash Flow | $104.5M | $44.2M | $39.7M | $59.2M | $51.1M | $45.0M | $12.6M | $24.3M |